Kayode Raheem

Mr. Kayode Raheem

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2023 in Journal of Molecular Structure
Verified
Journal Article
Closed access
MRMouhamed Z K A Raimi
Mouhamed Z K A Raimi
ANAneeqa Nadeem
Aneeqa Nadeem
KRKayode Raheem
Kayode Raheem
GHGhulam HUSSAIN
Ghulam HUSSAIN
NZNousheen Zafeer
Nousheen Zafeer
ASAsghar Shabbir
Asghar Shabbir

11 November 2022 in Journal of Molecular Structure
Verified
Journal Article
Closed access
BABirnur Akkaya
Birnur Akkaya
RARecep Akkaya
Recep Akkaya
SCSümeyye Idil Celikkaya
Sümeyye Idil Celikkaya
NSNurgül Sarıaydin
Nurgül Sarıaydin
KRKayode Raheem
Kayode Raheem

1 January 2023 in Advances in Biomarker Sciences and Technology
Verified
Journal Article
Open access
KRKayode Raheem
Kayode Raheem
FIFawehinmi Praise Ibukunoluwa
Fawehinmi Praise Ibukunoluwa
SOSolomon Ayodele Olorundare
Solomon Ayodele Olorundare
JNJairus Nandwa
Jairus Nandwa
MAModinat Aina Abayomi
Modinat Aina Abayomi
FDFalana Taiwo Daniel
Falana Taiwo Daniel

15 October 2022 in Journal of Molecular Structure
Verified
Journal Article
Closed access
NİNihal İNANDIKLIOĞLU
Nihal İNANDIKLIOĞLU
ATAyca Tas
Ayca Tas
TATugba Agbektas
Tugba Agbektas
ZTZuhal Tuncbilek
Zuhal Tuncbilek
KRKayode Raheem
Kayode Raheem
YSYavuz Silig
Yavuz Silig

22 October 2025 in Discover Oncology
Verified
Journal Article
Open access
PDF file
SUSaviour God'swealth Usin
Saviour God'swealth Usin
DNDaniel Ogbonnaya Nwankwo
Daniel Ogbonnaya Nwankwo
ARAnas Haruna Ruggah
Anas Haruna Ruggah
AAAyomide Oluwadarasimi Adebesin
Ayomide Oluwadarasimi Adebesin
MAMd. Ahad Ali
Md. Ahad Ali
TBToheeb Balogun
Toheeb Balogun
Background Breast cancer is one of the most common cancer types among women, especially in developing and underdeveloped nations like Nigeria. Anexelekto (AXL) is one of the well-known proteins that is implicated in various cancer types, including breast cancer, and it remains one of the focuses of targeted therapy. However, several drugs have been identified as inhibitors of this oncogenic protein, but they often come with toxic concerns in addition to their unaffordability to people of low- or middle-income countries. Thus, there is a crucial need to identify pocket-friendly inhibitors with negligible side effects targeting AXL. Therefore, bioactive compounds from plants such as Echinacea purpurea may be a promising agent in this regard. Objective The study sought to investigate the potential of bioactive compounds derived from Echinacea purpurea to inhibit the AXL protein implicated in breast cancer. Methods Structural bioinformatics via molecular docking and density functional theory (DFT) analysis was utilised for the identification of novel AXL inhibitors from Echinacea purpurea bioactive compounds. The compounds were further subjected to pharmacokinetic and drug-likeness analysis. Results obtained from the compounds were compared against those of Foretinib, a known AXL inhibitor. Additionally, their complexes with AXL were subjected to a 100 ns molecular dynamics (MD) simulation analysis utilising the Desmond v2020-4 software in Schrödinger (Academic version) in a Linux environment. Results Among all favourable binding scores, Kaempferol-7-o-Neohesperidoside, Kaempferol 3-gentiobioside-7-rhamnoside, and Kaempferol 3-o-beta-d-glucopyranosyl-7-o-alpha-L-rhamnopyranoside showed the highest binding score of -9.2, -8.9, and − 8.6 Kcal/mol, respectively, compared to Foretinib (-8.1 Kcal/mol). Stigmasterol and β-sitosterol also showed a higher binding affinity and binding score of -8.4 and − 8.3 Kcal/mol, respectively, against the AXL compared to the standard drug. DFT analysis revealed that Kaempferol 3-o-beta-d-glucopyranosyl-7-o-alpha-L-rhamnopyranoside has the highest LUMO-HOMO gap of -4.354 eV, suggesting greater potential for electron donation and high drug-enzyme reactivity. Also, the pharmacokinetic profiling of the selected compounds is favourable. Findings from MD simulation showed that the protein-ligand complexes formed by these compounds maintained structural stability, compactness, and low atomic fluctuations throughout a 100-ns simulation period. Conclusion In silico studies show that E. purpurea-derived compounds, especially Kaempferol 3-o-beta-d-glucopyranosyl-7-o-alpha-L-rhamnopyranoside, have better inhibitory potential against AXL and better pharmacokinetic profiles when compared with Foretinib. These compounds are thus proposed as novel AXL inhibitors for the treatment of breast cancer. Further, in vivo studies are needed to confirm the potency of the studied compounds.

2 July 2023 in Cukurova Medical Journal
Verified
Journal Article
Open access
PDF file
ÖBÖzlem Balbaloğlu
Özlem Balbaloğlu
NINihal İnAndiklioglu
Nihal İnAndiklioglu
KRKayode Raheem
Kayode Raheem
Purpose: The most important clinical finding of fibromyalgia syndrome (FMS) is pain. Its etiology has not been fully elucidated. This study was planned to determine the relationship between endocan, ET-1, IL-1, IL-6, IL-8, MCP-1, TNF-a, VEGF-A levels and pain/neuropathic pain in FMS patients. Materials and Methods: Forty-four FMS patients who met the inclusion criteria and 44 age-matched premenopausal healthy controls were recruited. The fibromyalgia group was evaluated in terms of Visual Analog Scale, Beck Depression Scale, Beck Anxiety Scale, Fibromyalgia Impact Questionnaire and LANSS Pain Scale. Serum endocan, ET-1, IL-1, IL-6, IL-8, MCP-1, TNF-α, and VEGF-A values were determined by the ELISA method. Protein-protein interaction was evaluated by molecular docking analysis. Bioinformatics analysis was performed using the STRING v 11.5 protein interaction tool. Results: Endocan, ET-1, IL-1, IL-6, IL-8, MCP-1, TNF-α, and VEGF-A were significantly higher in FMS patients than the control group. 24 of 44 patients had neuropathic pain. No correlation was found between pain/neuropathic pain and serum markers levels. High interaction and homology scores of the proteins were defined. Conclusion: The pain/neuropathic pain relationship of these markers could not be determined, but the calculated binding energies and activities of the proteins provided important clues for future studies.